Palantir is now trading at about 105x forward P/S ratio, making other best-of-breed cloud names like Cloudflare and ...

NEW YORK, NY / ACCESS Newswire / October 30, 2025 / In the face of growing global concern over the potential use of chemical weapons such as the nerve agent Sarin, Lunai Bioworks Inc. (NASDAQ:LNAI) ...

Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine ...

Q3 2025 Earnings Call Transcript October 29, 2025 MiMedx Group, Inc. beats earnings expectations. Reported EPS is $0.15, ...

Vivan Therapeutics is a pioneer in cancer treatment innovation through its novel approach to personalized medicine. By using ...